Alibaba Health Information Technology Ltd
00241: XHKG (HKG)
| Morningstar Rating for Stocks | Fair Value | Economic Moat | Capital Allocation |
|---|---|---|---|
| HKD 8.00 | Gnxncx | Dbrrbfdz |
Alibaba Health’s Narrow Moat Is Intact Despite Increasing Concerns About Softer Long-Term Demand
Business Strategy and Outlook
We expect narrow-moat Alibaba Health, or AliHealth, to benefit from low saturation in healthcare e-commerce. The business is still in the early phase where it is focused on mass user adoption and should see robust growth in the near term, and now is set to integrate advertising business into its platform to another incremental revenue stream. It also plans to add cloud-based AI to develop the platform into a one-stop shop for healthcare products, services, and digital hospital for its users.